Novatis Investigative Site — Upland, Pennsylvania

Novatis Investigative Site is a clinical research site located in Upland, Pennsylvania, United States 19013.

Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.

Novatis Investigative Site has participated in 1 clinical trials.

Therapeutic areas: Persistent Asthma.

Sponsors: Novartis Pharmaceuticals.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Upland

Browse all research sites in Pennsylvania · View every site in Upland

• Crozer Chester Medical Center
• Associates In Hematology Oncology PC-Upland
• GSK Investigational Site
• Research Site
• Associates in Hematology-Oncology, PC at Crozer Regional Cancer Center
• Asthma and Allergy Research Associates
• Asthma and Allergy Research Associate
• Pfizer Investigational Site
• Associates in Hematology-Oncology, P.C.
• Asthma & Allergy Research Associates
• Neurological Associates of Delaware Valley
• Altana/Nycomed

Sponsor Feasibility Report

Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Novatis Investigative Site?

Novatis Investigative Site has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Novatis Investigative Site conducted?

Novatis Investigative Site has 1 clinical trials on record. Their work covers Persistent Asthma.

Is Novatis Investigative Site accredited by Crixeo Clinical Trials?

Novatis Investigative Site has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Novatis Investigative Site?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.